Searched for: in-biosketch:true
person:segevd01
Characterizing the landscape and impact of infections following kidney transplantation
Jackson, Kyle R; Motter, Jennifer D; Bae, Sunjae; Kernodle, Amber; Long, Jane J; Werbel, William; Avery, Robin; Durand, Christine; Massie, Allan B; Desai, Niraj; Garonzik-Wang, Jacqueline; Segev, Dorry L
Infections remain a major threat to successful kidney transplantation (KT). To characterize the landscape and impact of post-KT infections in the modern era, we used United States Renal Data System (USRDS) data linked to the Scientific Registry of Transplant Recipients (SRTR) to study 141Â 661 Medicare-primary kidney transplant recipients from January 1, 1999 to December 31, 2014. Infection diagnoses were ascertained by International Classification of Diseases, Ninth Revision (ICD-9) codes. The cumulative incidence of a post-KT infection was 36.9% at 3Â months, 53.7% at 1Â year, and 78.0% at 5Â years. The most common infections were urinary tract infection (UTI; 46.8%) and pneumonia (28.2%). Five-year mortality for kidney transplant recipients who developed an infection was 24.9% vs 7.9% for those who did not, and 5-year death-censored graft failure (DCGF) was 20.6% vs 10.1% (PÂ <Â .001). This translated to a 2.22-fold higher mortality risk (adjusted hazard ratio [aHR]: 2.15 2.222.29 , PÂ <Â .001) and 1.92-fold higher DCGF risk (aHR: 1.84 1.911.98 , PÂ <Â .001) for kidney transplant recipients who developed an infection, although the magnitude of this higher risk varied across infection types (for example, 3.11-fold higher mortality risk for sepsis vs 1.62-fold for a UTI). Post-KT infections are common and substantially impact mortality and DCGF, even in the modern era. Kidney transplant recipients at high risk for infections might benefit from enhanced surveillance or follow-up to mitigate these risks.
PMID: 32506639
ISSN: 1600-6143
CID: 5126422
Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study [Letter]
Durand, Christine M; Barnaba, Brittany; Yu, Sile; Brown, Diane M; Chattergoon, Michael A; Bair, Nichole; Naqvi, Fizza F; Sulkowski, Mark; Segev, Dorry L; Desai, Niraj M
PMCID:8288461
PMID: 32894697
ISSN: 1539-3704
CID: 5126682
DYNAMIC PREDICTION OF KIDNEY GRAFT SURVIVAL WITH ARTIFICIAL INTELLIGENCE: AN INTERNATIONAL STUDY OF DEEP COHORTS OF KIDNEY RECIPIENTS [Meeting Abstract]
Raynaud, Marc; Aubert, Olivier; Reese, Peter; Kamar, Nassim; Chin, Chen-Shan; Bailly, Elodie; Ladriere, Marc; Le Quintrec, Moglie; Delahousse, Michel; Juric, Ivana; Basic-Jukic, Nikolina; Crespo, Marta; Silva Junior, Helio Tedesco; Linhares, Kamilla; de Castro, Maria Cristina Ribeiro; Gervacio, Soler Pujol; Yoo, Daniel; Empana, Jean-Philippe; Ulloa, Camilo; Akalin, Enver; Boehmig, Georg; Huang, Edmund; Glotz, Denis; Jordan, Stanley; Bentall, Andrew; Montgomery, Robert; Oberbauer, Rainer; Segev, Dorry; Friedewald, John; Legendre, Christophe; Jouven, Xavier; Lefaucheur, Carmen; Loupy, Alexandre
ISI:000689725500008
ISSN: 0934-0874
CID: 5133202
TACKLING PERSISTENT HEALTH DISPARITIES IN THE LIVER TRANSPLANT EVALUATION PROCESS: A MULTI-CENTER ANALYSIS OF PROVIDER PERSPECTIVES ON MECHANISMS AND OPPORTUNITIES TO ADVANCE EQUITY [Meeting Abstract]
Strauss, Alexandra T.; Sidoti, Carolyn N.; Jain, Vedant S.; Sung, Hannah C.; Gurses, Ayse; Jackson, John; Levan, Macey L.; Levin, Scott; Gray, Stephen H.; Segev, Dorry L.; Gurakar, Ahmet; Wang, Jacqueline G.; Hamilton, James P.; Purnell, Tanjala S.
ISI:000707188000179
ISSN: 0270-9139
CID: 5133332
LIMITED IMMUNOGENICITY OF A SINGLE DOSE OF SARS-CoV-2 MRNA VACCINE IN SOLID ORGAN TRANSPLANT RECIPIENTS [Meeting Abstract]
Boyarsky, Brian; Ou, Michael; Greenberg, Ross; Teles, Aura; Werbel, William; Avery, Robin K.; Tobian, Aaron; Massie, Allan; Segev, Dorry; Garonzik-Wang, Jacqueline
ISI:000689725500551
ISSN: 0934-0874
CID: 5133232
EARLY SAFETY OF SARS-CoV-2 MRNA VACCINES IN SOLID ORGAN TRANSPLANT RECIPIENTS [Meeting Abstract]
Ou, Michael; Boyarsky, Brian; Motter, Jennifer; Greenberg, Ross; Teles, Aura; Ruddy, Jake; Krach, Michelle; Werbel, William; Avery, Robin K.; Massie, Allan; Segev, Dorry; Garonzik-Wang, Jacqueline
ISI:000689725500549
ISSN: 0934-0874
CID: 5133222
PRE-TRANSPLANT FRAILTY IS A KEY DETERMINANT OF GLOBAL FUNCTIONAL HEALTH AFTER LIVER TRANSPLANTATION: FROM THE MULTICENTER FUNCTIONAL ASSESSMENT IN LIVER TRANSPLANTATION (FRAILT) STUDY [Meeting Abstract]
Lai, Jennifer Cindy; Shui, Amy; Rahimi, Robert S.; Ganger, Daniel R.; Verna, Elizabeth C.; Volk, Michael; Kappus, Matthew R.; Ladner, Daniela P.; Boyarsky, Brian J.; Segev, Dorry L.; Gao, Ying; Huang, Chiung-Yu; Singer, Jonathan; Duarte-Rojo, Andres
ISI:000707188004220
ISSN: 0270-9139
CID: 5133362
When One Size Does Not Fit All: Geographically Heterogeneous Liver Distribution [Meeting Abstract]
Mankowski, M. A.; Gentry, S.; Segev, D.; Trichakis, N.
ISI:000705310103116
ISSN: 1600-6135
CID: 5486632
FRAILTY AND KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS [Meeting Abstract]
Quint, Evelien; Zogaj, Donika; Banning, Wiesje; Benjamens, Stan; Annema, Coby; Bakker, Stephan; Nieuwenhuijs-Moeke, Gertrude; Segev, Dorry; Mcadams-Demarco, Mara; Pol, Robert
ISI:000689725500292
ISSN: 0934-0874
CID: 5133212
Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases [Letter]
Connolly, Caoilfhionn M.; Ruddy, Jake A.; Boyarsky, Brian J.; Avery, Robin K.; Werbel, William A.; Segev, Dorry L.; Garonzik-Wang, Jacqueline; Paik, Julie J.
ISI:000675434700039
ISSN: 0003-4967
CID: 5133122